eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neurofibromatosis |
| Comorbidity | C0206728|plexiform neurofibromas |
| Sentences | 8 |
| PubMedID- 22407214 | The objective of this study was to investigate the predictive value of [18f]-fluorodeoxyglucose positron emission tomography (fdg-pet) in detecting malignant transformation of plexiform neurofibromas in children with neurofibromatosis type 1 (nf1). |
| PubMedID- 21415691 | Resection of plexiform neurofibromas in children with neurofibromatosis type 1. |
| PubMedID- 23598713 | Purpose: the aim of this study was to analyze growth rate and identify prognostic factors for progression of postoperative plexiform neurofibromas in patients with neurofibromatosis type 1. |
| PubMedID- 24681606 | Malignant peripheral nerve sheath tumors (mpnsts) are soft tissue sarcomas that occur spontaneously, or from benign plexiform neurofibromas, in the context of the genetic disorder neurofibromatosis type 1 (nf1). |
| PubMedID- 20680410 | plexiform neurofibromas commonly found in patients with neurofibromatosis type i (nf1) have a 5% risk of being transformed into malignant peripheral nerve sheath tumors (mpnst). |
| PubMedID- 23035791 | Background: to examine the natural growth dynamics of internal plexiform neurofibromas (pns) in patients with neurofibromatosis 1 (nf1). |
| PubMedID- 23099009 | Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial. |
| PubMedID- 21621223 | plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits. |
Page: 1